These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26734951)

  • 1. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.
    Parman Y; Adams D; Obici L; Galán L; Guergueltcheva V; Suhr OB; Coelho T;
    Curr Opin Neurol; 2016 Feb; 29 Suppl 1(Suppl 1):S3-S13. PubMed ID: 26734951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy.
    Adams D; Suhr OB; Hund E; Obici L; Tournev I; Campistol JM; Slama MS; Hazenberg BP; Coelho T;
    Curr Opin Neurol; 2016 Feb; 29 Suppl 1(Suppl 1):S14-26. PubMed ID: 26734952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis.
    Obici L; Kuks JB; Buades J; Adams D; Suhr OB; Coelho T; Kyriakides T;
    Curr Opin Neurol; 2016 Feb; 29 Suppl 1(Suppl 1):S27-35. PubMed ID: 26734953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
    Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthyretin familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Kerschen P
    Handb Clin Neurol; 2013; 115():643-58. PubMed ID: 23931808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
    Schmidt HH; Barroso F; González-Duarte A; Conceição I; Obici L; Keohane D; Amass L
    Muscle Nerve; 2016 Sep; 54(3):353-60. PubMed ID: 27273296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
    Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
    J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
    Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
    Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study.
    Inês M; Coelho T; Conceição I; Duarte-Ramos F; de Carvalho M; Costa J
    Neuroepidemiology; 2018; 51(3-4):177-182. PubMed ID: 30153683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.
    Rudolph T; Kurz MW; Farbu E
    Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy.
    Plante-Bordeneuve V
    J Neurol; 2014 Jun; 261(6):1227-33. PubMed ID: 24888313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
    Ikeda S; Nakazato M; Ando Y; Sobue G
    Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Said G
    Lancet Neurol; 2011 Dec; 10(12):1086-97. PubMed ID: 22094129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAP neuropathy and emerging treatments.
    Adams D; Théaudin M; Cauquil C; Algalarrondo V; Slama M
    Curr Neurol Neurosci Rep; 2014 Mar; 14(3):435. PubMed ID: 24482069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional difference and similarity of familial amyloidosis with polyneuropathy in France.
    Adams D; Lozeron P; Theaudin M; Mincheva Z; Cauquil C; Adam C; Signate A; Vial C; Maisonobe T; Delmont E; Franques J; Vallat JM; Sole G; Pereon Y; Lacour A; Echaniz-Laguna A; Misrahi M; Lacroix C;
    Amyloid; 2012 Jun; 19 Suppl 1():61-4. PubMed ID: 22620968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.
    Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L
    J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
    Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
    Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina].
    Chaves M; Bettini M; Marciano S; Sáez S; Cristiano E; Rugiero M
    Medicina (B Aires); 2016; 76(2):105-8. PubMed ID: 27135849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor Yield of Routine Transthyretin Screening in Patients with Idiopathic Neuropathy.
    Namiranian D; Chalk C; Massie R
    Can J Neurol Sci; 2020 Nov; 47(6):816-819. PubMed ID: 32493526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.